Vireo Growth INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Vireo Growth Inc. reported a significant revenue increase of 333% to $106.2 million in Q1 2026, driven by strategic acquisitions and expanded operations.
OTC.Pink
Vireo Growth Inc. announced a significant revenue surge driven by recent acquisitions, despite reporting increased net losses for the quarter and nine months ended September 30, 2025.
OTC.Pink
Vireo Growth Inc. announced a significant revenue surge in Q2 2025, driven by recent strategic acquisitions, despite a widening net loss and declining gross margins.
OTC.Pink
Vireo Growth Inc. announces a marginal increase in revenue for Q1 2025, highlighting strategic realignments and merger agreements.
OTC.Pink
Vireo Growth Inc. saw a modest revenue increase in Q3 2024, driven by growth in Maryland, while navigating ongoing strategic changes and legal challenges.
OTC.Pink
Vireo Growth Inc. saw a 24% increase in revenue in the second quarter of 2024, driven by growth in Maryland, while navigating ongoing legal challenges and strategic asset sales.
OTC.Pink
Goodness Growth Holdings saw a 26% increase in revenue in Q1 2024, driven by Maryland's adult-use cannabis market, while navigating legal disputes and financial uncertainties.